Picture of Cann logo

CAN Cann Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Momentum

Relative Strength (%)
1m-6.83%
3m-10.4%
6m-33.85%
1yr-50.86%
Volume Change (%)
10d/3m+51.21%
Price vs... (%)
52w High-54.17%
50d MA-6.94%
200d MA-20.87%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-29.79%
Return on Equity-46.88%
Operating Margin-227.18%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202430th Jun 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Cann EPS forecast chart

Profile Summary

Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

Directors

Last Annual
June 30th, 2023
Last Interim
June 30th, 2023
Incorporated
January 30th, 2015
Public Since
May 4th, 2017
No. of Shareholders
26,220
No. of Employees
40
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
388,614,865

CAN Share Price Performance

Upcoming Events for CAN

Half Year 2024 Cann Group Ltd Earnings Release

Similar to CAN

Picture of Apiam Animal Health logo

Apiam Animal Health

au flag iconAustralian Stock Exchange - SEATS

Picture of Artrya logo

Artrya

au flag iconAustralian Stock Exchange - SEATS

Picture of Australian Clinical Labs logo

Australian Clinical Labs

au flag iconAustralian Stock Exchange - SEATS

Picture of Capitol Health logo

Capitol Health

au flag iconAustralian Stock Exchange - SEATS

Picture of Careteq logo

Careteq

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email